Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |